Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:03 PM ET Form 4
Insider Selling Frontdoor, Inc. FTDR

Frontdoor CEO William C. Cobb Sells $20.4M of Stock

William C. Cobb, CEO, sold 208,747 shares of Frontdoor, Inc. at $96.69 to $99.17 a share (average $97.67) in 3 transactions, worth $20.4M in total between Nov 10, 2026 and Nov 12, 2026. Shares held after the trade: 184,335 (-34.3%).

Value
$20.4M
Shares
208,747
Average price
$97.67
Role
CEO
Holding change
-34.3%
Trade date
Nov 10, 2026 to Nov 12, 2026
4:03 PM ET 8-K
Shareholder Meeting Elicio Therapeutics, Inc. ELTX

Elicio Therapeutics Shareholder Meeting

Elicio Therapeutics held its 2026 Annual Meeting of Stockholders on November 12, 2026. Shareholders elected three Class III directors (Julian Adams, Jay R. Venkatesan, and Carol Ashe) to three-year terms and ratified Baker Tilly US, LLP as the company's independent auditor for the fiscal year ending December 31, 2026.

4:03 PM ET 10-Q
Financial Results Siebert Financial Corp SIEB

Siebert Financial Q3 2026 Results: Net Loss of $711K

Siebert Financial Corp. reported a net loss of $3.0 million for the nine months ended September 30, 2026, compared to a net income of $5.6 million in the prior year period. While total revenue grew to $79.3 million, expenses surged to $83.7 million, driven by higher employee compensation, technology costs, and one-time settlement and impairment charges.

Key figure
Net loss $711K
4:03 PM ET 10-Q
Financial Results SilverBox Corp IV SBXDF

SilverBox Corp IV Q3 2026 Results: Net Income $610K, Down 4.3% YoY

SilverBox Corp IV reported a net income of $3.64 million for the nine months ended September 30, 2026, primarily driven by $4.77 million in interest earned on trust account investments. During the period, the company experienced significant redemptions, with $207.5 million withdrawn from the Trust Account, leaving $10.64 million in investments remaining.

Key figure
Net income $610K · -4.3% YoY
4:03 PM ET 10-Q
Financial Results BioKey (Cayman), Inc.

BioKey Q3 2026 Results: Net Loss of $398K, Loss Widens

BioKey (Cayman), Inc. reported zero revenue for the nine months ended September 30, 2026, with a net loss of $873,721 compared to $538,188 in the prior year period. The company remains heavily dependent on recurring loans from ABVC BioPharma, Inc. to support its operations, with total liabilities reaching $7.56 million against total assets of $1.61 million.

Key figure
Net loss $398K
4:03 PM ET 10-Q
Financial Results Arrive AI Inc. ARAI

Arrive AI Q3 2026 Results: Net Loss of $3.67M, Loss Narrows

Arrive AI Inc. reported a net loss of $24.1 million for the nine months ended September 30, 2026, compared to a $10.1 million loss in the prior year period, driven largely by a $12.3 million loss on the conversion of notes. Total assets decreased to $9.2 million from $10.9 million at year-end 2025, while the company maintained a stockholders' equity of $2.2 million.

Key figure
Net loss $3.67M
4:03 PM ET 10-Q
Financial Results Planet Green Holdings Corp. PLAG

Planet Green Holdings Q3 2026 Results: Net Loss of $454K, Loss Narrows

Planet Green Holdings Corp. reported a significant increase in net revenues to $9.58 million for the nine months ended September 30, 2026, compared to $67,270 in the prior year, though it still incurred a net loss of $1.04 million. The company's balance sheet shows a total stockholders' deficit of $3.06 million, and it continues to manage significant liabilities from discontinued operations.

Key figure
Net loss $454K
4:03 PM ET 8-K
Other 8-K Filing CNO Financial Group, Inc. CNO

CNO Financial Group Other 8-K Filing

CNO Financial Group entered into a Sixth Amended and Restated Section 382 Rights Agreement to extend its existing 'poison pill' through November 13, 2029. The agreement is designed to protect the company's tax net operating loss carryforwards by deterring any person from acquiring 4.99% or more of the company's outstanding common stock without board approval.

Counterparty
Equiniti Trust Company, LLC
Term
3 years
4:03 PM ET Form 4
Insider Selling Appian Corp APPN

Appian Insider Mark Steven Lynch Sells $507K of Stock

Mark Steven Lynch sold 9,533 shares of Appian Corp at $53.14 a share, worth $507K in total on Nov 11, 2026. Shares held after the trade: 37,981 (-20.1%).

Value
$507K
Shares
9,533
Price
$53.14
Holding change
-20.1%
Trade date
Nov 11, 2026
4:02 PM ET Form 4
Insider Selling Sensata Technologies Holding plc ST

Sensata Technologies Holding EVP, Chief HR Officer Lynne J. Caljouw Sells $309K of Stock

Lynne J. Caljouw, EVP, Chief HR Officer, sold 7,726 shares of Sensata Technologies Holding plc at $40.02 a share, worth $309K in total on Nov 10, 2026. Shares held after the trade: 58,679 (-11.6%).

Value
$309K
Shares
7,726
Price
$40.02
Role
EVP, Chief HR Officer
Holding change
-11.6%
Trade date
Nov 10, 2026
4:02 PM ET 8-K
Leadership Change Moderna, Inc. MRNA

Moderna Leadership Change

Moderna's Chief Legal Officer, Shannon Thyme Klinger, will retire from the company effective March 31, 2027. Under a transitional services agreement, she will receive $1.63 million in severance plus potential performance bonuses of up to $8 million tied to the outcomes of ongoing litigation with Arbutus, Genevant, Pfizer, and BioNTech.

4:02 PM ET 10-Q
Financial Results CCS IX Portfolio Holdings, LLC

CCS IX Portfolio Holdings Q3 2026 Results: Net Income $20.9M, Up 309.2% YoY

CCS IX Portfolio Holdings, LLC reported a significant increase in total investment income to $58.6 million for the nine months ended September 30, 2026, compared to $18.5 million in the prior year period. Net assets grew to $732.4 million, driven by $353.3 million in capital contributions and $31.6 million in net increase in net assets from operations.

Key figure
Net income $20.9M · +309.2% YoY
4:02 PM ET 10-Q
Financial Results Dyadic International Inc DYAI ▶ Call

Dyadic International Q3 2026 Results: Net Loss of $1.36M, Loss Narrows

Dyadic International reported a net loss of $5.4 million for the nine months ended September 30, 2026, compared to $5.8 million in the prior year. The company is undergoing a strategic rebranding to Dyadic Applied BioSolutions, shifting focus from research to commercialized protein production platforms across life sciences and food sectors.

Key figure
Net loss $1.36M
4:02 PM ET 8-K
Nasdaq/NYSE Compliance Notice aTYR Pharma INC ATYR

aTYR Pharma Nasdaq/NYSE Compliance Notice

aTyr Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock closed at or above $1.00 per share for 10 consecutive business days. The company had previously been under a deficiency notice since December 2025 and was granted an extension until November 30, 2026, to meet the standard. As of this filing, the company has no outstanding deficiency notices from Nasdaq.

Counterparty
Nasdaq
4:02 PM ET 10-Q
Financial Results Saga Communications Inc SGA

Saga Communications Q3 2026 Results: Net Loss of $7.09M, Loss Widens

Saga Communications reported a net loss of $7.1 million for the third quarter of 2026, primarily driven by a $9.2 million impairment of intangible assets. Net operating revenue decreased to $26.7 million from $28.2 million in the prior year period, while total assets declined to $183.0 million as of September 30, 2026.

Key figure
Net loss $7.09M
4:02 PM ET 10-Q
Financial Results Waterstone Financial, Inc. WSBF

Waterstone Financial Q3 2026 Results: Net Income $6.17M, Down 22.1% YoY

Waterstone Financial, Inc. reported net income of $20.6 million for the nine months ended September 30, 2026, an increase from $18.7 million in the prior year period. The company experienced a decrease in total assets to $2.25 billion, primarily driven by a reduction in loans held for sale and cash equivalents, while net interest income improved due to lower interest expenses on deposits and borrowings.

Key figure
Net income $6.17M · -22.1% YoY
4:01 PM ET 10-Q
Financial Results Spectral Capital Corp FCCN

Spectral Capital Q3 2026 Results: Net Loss of $3.37M, Loss Widens

Spectral Capital Corporation reported a significant revenue increase to $865.9 million for the nine months ended September 30, 2026, compared to $3.1 million in the prior year, primarily driven by business combinations. Despite the revenue growth, the company realized a net loss of $5.4 million for the period due to high cost of revenues and increased operating expenses.

Key figure
Net loss $3.37M
4:01 PM ET Form 4
Insider Selling Beta Bionics, Inc. BBNX

Beta Bionics CFO Stephen Feider Sells $153K of Stock

Stephen Feider, CFO, sold 8,874 shares of Beta Bionics, Inc. at $17.21 a share, worth $153K in total on Nov 11, 2026. Shares held after the trade: 159,378 (-5.3%).

Value
$153K
Shares
8,874
Price
$17.21
Role
CFO
Holding change
-5.3%
Trade date
Nov 11, 2026
4:01 PM ET Form 4
Insider Buying Drilling Tools International Corp DTI

Drilling Tools International CEO Robert Wayne Prejean Buys $17.7K of Stock

Robert Wayne Prejean, CEO, bought 10,000 shares of Drilling Tools International Corp at $1.77 a share, worth $17.7K in total on Nov 12, 2026. Shares held after the trade: 601,076 (+1.7%).

Value
$17.7K
Shares
10,000
Price
$1.77
Role
CEO
Holding change
+1.7%
Trade date
Nov 12, 2026
4:01 PM ET 10-Q
Financial Results Pmgc Holdings Inc. ELAB

Pmgc Holdings Q3 2026 Results: Net Loss of $2.41M, Loss Narrows

PMGC Holdings Inc. reported a significant revenue increase to $4.52 million for the nine months ended September 30, 2026, compared to $0.29 million in the prior year. However, net loss widened to $10.15 million due to increased operating expenses and interest costs, while the company underwent a series of reverse stock splits totaling 1-for-240.

Key figure
Net loss $2.41M
4:01 PM ET Form 4
Insider Buying Drilling Tools International Corp DTI

Drilling Tools International Director Eric C. Neuman Buys $66.3K of Stock

Eric C. Neuman, Director, bought 37,267 shares of Drilling Tools International Corp at $1.78 a share, worth $66.3K in total on Nov 12, 2026. Shares held after the trade: 378,789 (+10.9%).

Value
$66.3K
Shares
37,267
Price
$1.78
Role
Director
Holding change
+10.9%
Trade date
Nov 12, 2026
4:01 PM ET Form 4
Insider Selling Mgic Investment Corp MTG

Mgic Investment VP-CAO Julie K. Sperber Sells $230K of Stock

Julie K. Sperber, VP-CAO, sold 8,265 shares of Mgic Investment Corp at $27.79 a share, worth $230K in total on Nov 12, 2026. Shares held after the trade: 74,572 (-10.0%).

Value
$230K
Shares
8,265
Price
$27.79
Role
VP-CAO
Holding change
-10.0%
Trade date
Nov 12, 2026
4:01 PM ET Form 4
Insider Buying NextCure, Inc. NXTC

NextCure Insider ADAR1 Capital Management LLC Buys $62.9K of Stock

ADAR1 Capital Management LLC bought 12,333 shares of NextCure, Inc. at $5.10 a share, worth $62.9K in total on Nov 11, 2026. Shares held after the trade: 750,289 (+1.7%).

Value
$62.9K
Shares
12,333
Price
$5.10
Holding change
+1.7%
Trade date
Nov 11, 2026
4:01 PM ET 8-K
Financial Results Waterstone Financial, Inc. WSBF

Waterstone Financial Financial Results

Waterstone Financial reported Q3 2026 net income of $6.2 million, or $0.36 per diluted share, down from $7.9 million in the prior year quarter. The Community Banking segment achieved record quarterly net interest income of $16.0 million, while the Mortgage Banking segment faced a pre-tax loss of $754,000 due to rising mortgage rates and compressed sales margins.

Term
Q3 2026

“We are pleased with the hard work to reach another strong quarter with increased challenges from rising short-term and long-term treasury rates. The Community Banking segment realized another record quarterly net interest income of $16.0 million, which represented a $1.4 million increase compared to the quarter ended September 30, 2025.”

William Bruss, Chief Executive Officer of Waterstone Financial, Inc.
4:01 PM ET 8-K
Leadership Change Advasa Holdings, Inc. ADBT

Advasa Holdings Leadership Change

Advasa Holdings, Inc. appointed Andre Thompson as an Independent Non-Executive Director to its Board of Directors, effective November 10, 2026. Mr. Thompson will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, acting as chairperson for the latter. He brings over 20 years of experience in real estate development and will receive standard independent director compensation.

Counterparty
Andre Thompson
4:01 PM ET 8-K
Court & Legal Update Tonix Pharmaceuticals Holding Corp. TNXP

Tonix Pharmaceuticals Holding Court & Legal Update

Tonix Pharmaceuticals filed a patent infringement lawsuit against Dr. Reddy’s Laboratories in the U.S. District Court for the District of New Jersey following a Paragraph IV certification regarding TONMYA®. The filing of the complaint triggers a statutory 30-month stay of final FDA approval for Dr. Reddy’s proposed generic version of the drug. Tonix seeks to prevent generic competition until the expiration of its Orange Book-listed patents.

Counterparty
Dr. Reddy’s Laboratories Ltd.
Term
30 months
4:01 PM ET Form 4
Insider Selling Affirm Holdings, Inc. AFRM

Affirm Holdings Insider Noel Bertram Watson Sells $134K of Stock

Noel Bertram Watson sold 2,000 shares of Affirm Holdings, Inc. at $66.90 a share, worth $134K in total on Nov 10, 2026. Shares held after the trade: 32,076 (-5.9%).

Value
$134K
Shares
2,000
Price
$66.90
Holding change
-5.9%
Trade date
Nov 10, 2026
4:01 PM ET 10-Q
Financial Results Actuate Therapeutics, Inc. ACTU

Actuate Therapeutics Q3 2026 Results: Net Loss of $3.42M, Loss Narrows

Actuate Therapeutics reported a net loss of $13.9 million for the nine months ended September 30, 2026, compared to $17.7 million in the prior year period. The company's cash position decreased significantly to $2.1 million, resulting in a working capital deficit and a stated going concern uncertainty as it continues to fund clinical development of elraglusib.

Key figure
Net loss $3.42M
4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Amesite Inc. AMST

Amesite Nasdaq/NYSE Compliance Notice

Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
4:01 PM ET 8-K
Executive Compensation First National Corp FXNC

First National Executive Compensation

First National Corporation entered into a new Supplemental Executive Retirement Plan (2026 SERP) with President and CEO Scott C. Harvard, providing a one-time lump sum retirement benefit of $2,376,298. The benefit is payable within 30 days of his separation from service for any reason other than cause. Additionally, the company amended Mr. Harvard's existing 2014 employment agreement to reflect the new SERP terms.

Counterparty
Scott C. Harvard

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.